Get started
Author

Shinichi Uchida

Observed name: Shin-ichi Uchida
Institution: Kyowa Kirin (Japan)
ORCID: 0009-0009-2704-0065
Observed ORCID: 0009-0009-2704-0065
OpenAlex ID: A5102756903
Novel lactopeptides in fermented dairy products improve memory function and cognitive decline
2018 · Yasuhisa Ano, Tatsuhiro Ayabe, et al. · Neurobiology of Aging · 115
PDF
Effect of a centrally active angiotensin-converting enzyme inhibitor, perindopril, on cognitive performance in a mouse model of Alzheimer's disease
2010 · Koji Yamada, Shinichi Uchida, et al. · Brain Research · 99
The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson’s Disease
2022 · Akihisa Mori, Jiang-Fan Chen, et al. · Molecules · 67
PDF
The Adenosine A2A-Receptor Antagonist Istradefylline Enhances the Motor Response of L-DOPA Without Worsening Dyskinesia in MPTP-Treated Common Marmosets
2014 · Shin-ichi Uchida, Tomomi Tashiro, et al. · Journal of Pharmacological Sciences · 44
PDF
The adenosine A2A receptor antagonist, istradefylline enhances anti-parkinsonian activity induced by combined treatment with low doses of L-DOPA and dopamine agonists in MPTP-treated common marmosets
2015 · Shin-ichi Uchida, Kazuhiro Soshiroda, et al. · European Journal of Pharmacology · 35
Iso‐α‐acids, the bitter components of beer, improve hippocampus‐dependent memory through vagus nerve activation
2019 · Yasuhisa Ano, Ayaka Hoshi, et al. · The FASEB Journal · 29
PDF
Identification of a Novel Peptide from β-Casein That Enhances Spatial and Object Recognition Memory in Mice
2019 · Yasuhisa Ano, Toshiko Kutsukake, et al. · Journal of Agricultural and Food Chemistry · 28
Effects of the Adenosine A2A Receptor Antagonist on Cognitive Dysfunction in Parkinson's Disease
2014 · Shin-ichi Uchida, Takako Kadowaki-Horita, et al. · International review of neurobiology · 28
Anxiolytic effects of theaflavins via dopaminergic activation in the frontal cortex
2019 · Masahiro Kita, Shinichi Uchida, et al. · Bioscience Biotechnology and Biochemistry · 24
Clinical/Pharmacological Aspect of Adenosine A2A Receptor Antagonist for Dyskinesia
2014 · Tomoyuki Kanda, Shin-ichi Uchida · International review of neurobiology · 20
Synthetic studies on selective adenosine A2A receptor antagonists. Part II: Synthesis and structure–activity relationships of novel benzofuran derivatives
2010 · Osamu Saku, Mayumi Saki, et al. · Bioorganic & Medicinal Chemistry Letters · 18
In Vitro Pharmacological Profile of KW-6356, a Novel Adenosine A2A Receptor Antagonist/Inverse Agonist
2023 · Yutaro Ohno, Michihiko Suzuki, et al. · Molecular Pharmacology · 16
How Are Adenosine and Adenosine A2A Receptors Involved in the Pathophysiology of Amyotrophic Lateral Sclerosis?
2021 · Akihisa Mori, Brittany Cross, et al. · Biomedicines · 13
PDF
Novel 4-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)methylbenzofuran derivatives as selective α2C-adrenergic receptor antagonists
2007 · Koji Hagihara, Hajime Kashima, et al. · Bioorganic & Medicinal Chemistry Letters · 8
Anti-parkinsonian activity of the adenosine A2A receptor antagonist/inverse agonist KW-6356 as monotherapy in MPTP-treated common marmosets
2023 · Yutaro Ohno, Eri Okita, et al. · European Journal of Pharmacology · 7
The adenosine A2A receptor antagonist/inverse agonist, KW-6356 enhances the anti-parkinsonian activity of L-DOPA with a low risk of dyskinesia in MPTP-treated common marmosets
2023 · Yutaro Ohno, Eri Okita, et al. · Journal of Pharmacological Sciences · 6
High-dose carbidopa achieves sustained levodopa pharmacokinetics and efficacy in Parkinson’s disease models
2025 · Akane Hayashi, Atsushi Hosomi, et al. · Journal of Pharmacy and Pharmacology
[P2–038]: ISO‐α‐ACIDS, BITTER COMPONENTS OF BEER, IMPROVES OBESITY‐INDUCED COGNITIVE DECLINE
2017 · Tatsuhiro Ayabe, Shinichi Uchida, et al. · Alzheimer s & Dementia
PDF
Works count: 18
Citation count: 557
H-index: 13
I10-index: 13
Year
Topic
Type